Pesquisar um ensaio clínico
Outras opções de pesquisa
11 Resultado(s)
Ensaio em fase de recrutamento = 
; Ensaio a decorrer = 
; Financiado por um membro do IRDiRC = 
; Membro de uma ERN = 
Ensaio (s) clínico (s) nacional (is)
ALEMANHA
Baden-Württemberg
ULM
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitäts- und Rehabilitationskliniken Ulm (RKU)
Klinik für Neurologie
ALEMANHA
Bayern
MÜNCHEN
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
LMU Klinikum der Universität München - Campus Großhadern
Institut für Klinische Neuroimmunologie
ALEMANHA
Bayern
WÜRZBURG
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Neurologische Klinik und Poliklinik des Universitätsklinikums Würzburg
Neurologische Klinik und Poliklinik
ALEMANHA
Berlin
BERLIN
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Charité - Universitätsmedizin Berlin (CCM)
Klinik für Neurologie (CCM)
ALEMANHA
Niedersachsen
HANNOVER
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Medizinische Hochschule Hannover
Abteilung Klinische Neuroimmunologie und Neurochemie
ALEMANHA
Nordrhein-Westfalen
BOCHUM
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Neurologisches Universtätsklinikum im St. Josef-Hospital
Klinik für Neurologie
ALEMANHA
Nordrhein-Westfalen
MÜNSTER
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Münster
Klinik für Neurologie mit Institut für Translationale Neurologie
ALEMANHA
Rheinland-Pfalz
MAINZ
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsmedizin Mainz
Klinik und Poliklinik für Neurologie
ALEMANHA
Schleswig-Holstein
KIEL
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Klinik für Neurologie
ALEMANHA
Thüringen
JENA
Generate-Boost: A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis (CONNECT-GENERATE study)
Universitätsklinikum Jena
Hans-Berger-Klinik für Neurologie
REINO UNIDO
Oxfordshire
OXFORD